Neo-angin® 24's lozenges

The instruction for medical use of Neo-angin® medicine the Trade name of Neo-angin® the International unlicensed name Is not present the Dosage form of the Tablet for resorption Ingredients: 1 tablet for resorption contains active agents: alcohol of 2.4-dichlorbenzylic 1.20 mg left menthol of 5.90 mg amylmetacresol of 0.60 mg excipients: aniseed oil, oil mint, sucrose, glucose syrup, tartaric acid, Ponso dye 4R (E124). The description of the Tablet of red color, round shape, slightly biconvex form, with characteristic pleasant taste. Pharmacotherapeutic group Drugs for treatment of diseases of a throat. Antiseptic agents. Other drugs. The ATX R02AA20 code the Pharmacological Pharmacokinetics System Absorption properties a low Pharmacodynamics the Combined antiseptic drug for topical administration in a mouth and throat. It is active concerning gram-positive and gram-negative microorganisms and mushrooms. The main effect of 2-4-dichlorbenzyl alcohol and amylmetacresol is connected with superficial activity. Both substances interact with lipids of a cellular membrane of a bacterial cell that leads to its destruction. Left menthol complements effect with the analgeziruyushchy action based on stimulation of receptors mucous. Indications - infectious - inflammatory diseases of a mouth and throat. The route of administration and doses Appoint on 1 tablet each 2-3 hours. Tablets rassasyvat before full dissolution. Maximum daily dose of-6 tablets. Without the recommendation of the doctor not to take a pill for resorption of Neo-angin® more than 4-5 days. Side effects Are possible allergic reactions, dyspepsia. The contraindication - hypersensitivity to drug components - hereditary intolerance of sucrose, glyukozo-galaktozny malabsorption or sakharazo-izomaltazny insufficiency - children's age up to 18 years Medicinal interactions of Clinically significant interactions with other drugs is not revealed. Special instructions At preservation of symptoms it is necessary to consult with the doctor. Patients with diabetes have to consider that the tablet contains 2.6 g of sugar. Pregnancy and the period of a lactation Data on safety of use of drug during pregnancy and feeding by a breast are absent therefore use of drug is possible, considering the relation advantage/risk. Features of influence of medicine on ability to run transport and other potentially dangerous mechanisms the Overdose does not influence Cases of overdose are not known. A form of release and packing of the Tablet for resorption. On 12 tablets in blister strip packaging from a film of polyvinylchloride and aluminum foil. On 2 planimetric packs together with the instruction for use in the state and Russian languages place in a cardboard box. To Store storage conditions at a temperature not above 25 °C in the dry place. To store out of children's reach! 3 years not to apply a period of storage after the expiration date specified on packing. Prescription status Without prescription the Producer: DIVAFARMA GmbH Mottsener of curtains. 41 12277, Berlin, Germany Ph. (030) 72007-266 Owner of the registration certificate of DIVAFARMA GmbH Mottsener of curtains. 41 12277, Berlin, Germany Ph. (030) 72007-266 The address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products (goods) Representative office of LLC Astra Logistic Ltd (Astra Logistic Ltd) in the Republic of Kazakhstan, Central Asia and the Caucasus. 059000, Almaty, Igishev Street, 75. Ph. +7 (727) 3867597, 3867606, 3867599. Fax: +7 (727) 3867619. E-mail: info@alltd.kz. www.pharmaceuticals-forwarder.com. www.alltd.kz.